FDA ephedrine proposal comment deadline extension urged by Reps. Boyd, Farr.
This article was originally published in The Tan Sheet
Executive Summary
FDA EPHEDRINE PROPOSAL COMMENT EXTENSION URGED BY REPS. BOYD, FARR in recent letters to the agency. Allen Boyd (D-Fla.) and Sam Farr (D-Calif.) support the allowance of additional time to facilitate public input to the proposed rule, which would establish serving limits and label warnings for dietary supplements containing ephedrine alkaloids ("The Tan Sheet" June 9, pp. 20-23). Rep. Boyd, a member of the House Small Business Committee, states in a Nov. 12 letter that "the management of this rule has made it difficult, if not impossible, for small businesses to participate in the rulemaking process."
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning